On March 2, 2015, Dr. Andrew Mearns Spragg, General Manager of Jellagen, a medical technology company in the United Kingdom, and Ecz. Selçuk Haydanlı visited TÜBİTAK MAM KE in order to develop a joint project within the scope of EU Horizon 2020. Within the scope of the visit, Dr. Serdar Sezer, Deputy Director of TÜBİTAK MAM KE Institute, provided information about the projects carried out/planned in the medical field and the EU Horizon 2020 calls with private sector participation. Following the presentations of the projects open to possible cooperation, the company representatives visited TÜBİTAK MAM KE laboratories and received information about the relevant studies.
Share this News
For questions and suggestionsContact Us
Most Recent
National Polar Sciences Symposium and Polar Festival started
"9th National Polar Sciences Symposium and 5th Polar Festival" organized under the coordination of TUBITAK Polar Research Institute (KARE) started at Izmir Ege University....
ACLIFS Project Focus Group Meetings and 2nd Regional Workshop Completed in Izmir
The second series of Focus Group Meetings and 2nd Regional Workshop of the ACLIFS Project was held in Izmir for the Küçük Menderes Basin. The European Union and Turkey...
2232-A International Leading Researchers Program and 2232-B International Young Researchers Program 2025 Calls Opened
The 2025 calls for the 2232-A&B International Leader/Young Researchers Programs have been opened for applications as of 27 September 2025 and applications will be accepted on 24 November 2025.
Day of Innovative Projects in Hydropower with TÜBİTAK MAM's Visionary Approach
Under the leadership of TÜBİTAK Marmara Research Center (MAM), in cooperation with the Turkish Electricity Industry Association (TESAB) and TOBB University of Economics and Technology (ETU)...